{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:09:25Z","timestamp":1761919765949},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1097\/meg.0000000000000044","type":"journal-article","created":{"date-parts":[[2014,1,24]],"date-time":"2014-01-24T09:33:21Z","timestamp":1390556001000},"page":"438-443","source":"Crossref","is-referenced-by-count":13,"title":["Genetic polymorphisms of proangiogenic factors seem to favor hepatocellular carcinoma development in alcoholic cirrhosis"],"prefix":"10.1097","volume":"26","author":[{"given":"Mariana V.","family":"Machado","sequence":"first","affiliation":[]},{"given":"Andr\u00e9","family":"Janeiro","sequence":"additional","affiliation":[]},{"given":"Gabriel","family":"Miltenberger-Miltenyi","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Cortez-Pinto","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-10-20210207","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/lt.22330","article-title":"Liver transplantation in patients with alcoholic liver disease.","volume":"17","author":"Lucey","year":"2011","journal-title":"Liver Transpl"},{"key":"R2-10-20210207","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","article-title":"Alcoholic liver disease.","volume":"51","author":"OShea","year":"2010","journal-title":"Hepatology"},{"key":"R3-10-20210207","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(95)91685-7","article-title":"Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver.","volume":"346","author":"Teli","year":"1995","journal-title":"Lancet"},{"key":"R4-10-20210207","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1530-0277.1996.tb01695.x","article-title":"Genetic predisposition to organ-specific endpoints of alcoholism.","volume":"20","author":"Reed","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"key":"R5-10-20210207","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.25497","article-title":"Hypoxia and hypoxia inducible factors: diverse roles in liver diseases.","volume":"55","author":"Nath","year":"2012","journal-title":"Hepatology"},{"key":"R6-10-20210207","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1478-3231.2010.02369.x","article-title":"Angiogenesis in chronic liver disease and its complications.","volume":"31","author":"Coulon","year":"2011","journal-title":"Liver Int"},{"key":"R7-10-20210207","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/hep.1840090223","article-title":"Incomplete compensation of enhanced hepatic oxygen consumption in rats with alcoholic centrilobular liver necrosis.","volume":"9","author":"Tsukamoto","year":"1989","journal-title":"Hepatology"},{"key":"R10-10-20210207","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.1478-3231.2009.02015.x","article-title":"Hypoxia-inducible factor-dependent production of profibrotic mediators by hypoxic hepatocytes.","volume":"29","author":"Copple","year":"2009","journal-title":"Liver Int"},{"key":"R11-10-20210207","doi-asserted-by":"crossref","first-page":"G582","DOI":"10.1152\/ajpgi.90368.2008","article-title":"Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient mice.","volume":"296","author":"Moon","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R12-10-20210207","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.toxlet.2009.04.013","article-title":"Hepatocyte growth factor, vascular endothelial growth factor, glial cell-derived neurotrophic factor and nerve growth factor are differentially affected by early chronic ethanol or red wine intake.","volume":"188","author":"Fiore","year":"2009","journal-title":"Toxicol Lett"},{"key":"R14-10-20210207","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jhep.2009.06.024","article-title":"Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats.","volume":"51","author":"Reiberger","year":"2009","journal-title":"J Hepatol"},{"key":"R15-10-20210207","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1476-5381.2009.00158.x","article-title":"Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis.","volume":"157","author":"Hennenberg","year":"2009","journal-title":"Br J Pharmacol"},{"key":"R17-10-20210207","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1245\/s10434-007-9366-z","article-title":"High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.","volume":"14","author":"Poon","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R18-10-20210207","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1309\/FXNL-QTN1-94FH-AB3A","article-title":"Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1KDR in hepatocellular carcinoma.","volume":"116","author":"Ng","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"R20-10-20210207","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3748\/wjg.v10.i10.1533","article-title":"Effect of c-myc, Ki-67, MMP-2 and VEGF expression on prognosis of hepatocellular carcinoma patients undergoing tumor resection.","volume":"10","author":"Cui","year":"2004","journal-title":"World J Gastroenterol"},{"key":"R22-10-20210207","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ygyno.2009.11.011","article-title":"The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer.","volume":"117","author":"Steffensen","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R23-10-20210207","doi-asserted-by":"crossref","first-page":"21916","DOI":"10.1074\/jbc.M100763200","article-title":"Kinase insert domain receptor (KDR) extracellular immunoglobulin-like domains 4-7 contain structural features that block receptor dimerization and vascular endothelial growth factor-induced signaling.","volume":"276","author":"Tao","year":"2001","journal-title":"J Biol Chem"},{"key":"R27-10-20210207","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.5858\/2000-124-1061-IEOVEG","article-title":"Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis.","volume":"124","author":"Park","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"R28-10-20210207","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/hep.510280111","article-title":"Expression of vascular endothelial growth factor in human hepatocellular carcinoma.","volume":"28","author":"Yamaguchi","year":"1998","journal-title":"Hepatology"},{"key":"R30-10-20210207","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s10517-010-1043-8","article-title":"Vascular endothelial growth factor and its type 2 receptor in hepatocellular carcinoma.","volume":"149","author":"Gershtein","year":"2010","journal-title":"Bull Exp Biol Med"},{"key":"R33-10-20210207","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.arcmed.2009.07.011","article-title":"A single nucleotide polymorphism in the vascular endothelial growth factor gene is associated with recurrence of hepatocellular carcinoma after transplantation.","volume":"40","author":"Wu","year":"2009","journal-title":"Arch Med Res"},{"key":"R34-10-20210207","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/hep.21720","article-title":"Association between vascular endothelial growth factor gene polymorphisms and survival in hepatocellular carcinoma patients.","volume":"46","author":"Kong","year":"2007","journal-title":"Hepatology"},{"key":"R38-10-20210207","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0741-8329(93)90063-T","article-title":"Ethanol-inducible cytochrome P4502E1: genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease.","volume":"10","author":"Ingelman-Sundberg","year":"1993","journal-title":"Alcohol"},{"key":"R39-10-20210207","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2013.05.009","article-title":"Cytochrome P450 2E1 potentiates ethanol induction of hypoxia and HIF-1alpha in vivo.","volume":"63","author":"Wang","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"R40-10-20210207","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s10620-013-2574-4","article-title":"Chronic ingestion of ethanol induces hepatocellular carcinoma in mice without additional hepatic insult.","volume":"58","author":"Tsuchishima","year":"2013","journal-title":"Dig Dis Sci"}],"container-title":["European Journal of Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MEG.0000000000000044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:48:06Z","timestamp":1620964086000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042737-201404000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/meg.0000000000000044","relation":{},"ISSN":["0954-691X"],"issn-type":[{"value":"0954-691X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}